Showing results (421-430 of 491) with videos related to

Sort By:
Pageof 50
Heart (British Cardiac Society)|December 18, 2015
Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failureRichard M Cubbon, Naomi Ruff, David Groves, et al.
JAMA Cardiology|May 9, 2019
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF RegistryRamon Corbalan, Jean-Pierre Bassand, Laura Illingworth, et al.
American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.
Journal of the American College of Cardiology|May 12, 2012
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery diseaseEmanuele Barbato, Jozef Bartunek, Fabio Mangiacapra, et al.
Circulation|December 28, 2018
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial FibrillationJean-Pierre Bassand, Saverio Virdone, Samuel Z Goldhaber, et al.
European Heart Journal. Acute Cardiovascular Care|January 3, 2024
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelinesAntonio Landi, Victor Aboyans, Dominick J Angiolillo, et al.
BMJ Open|January 8, 2022
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registryKeith A A Fox, Saverio Virdone, Jean-Pierre Bassand, et al.
Circulation|November 25, 2016
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyC Michael Gibson, Duane S Pinto, Gerald Chi, et al.
Heart Rhythm|May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
International Journal of Cardiology|March 7, 2018
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AFAdam S Barnett, Derek D Cyr, Shaun G Goodman, et al.
Pageof 50